{"id":"https://openalex.org/W2116358656","doi":"https://doi.org/10.1248/cpb.50.1","title":"Pd Asymmetric Allylic Alkylation (AAA). A Powerful Synthetic Tool.","display_name":"Pd Asymmetric Allylic Alkylation (AAA). A Powerful Synthetic Tool.","alternate_titles":[],"publication_year":2002,"publication_date":"2002-01-01","ids":{"openalex":"https://openalex.org/W2116358656","doi":"https://doi.org/10.1248/cpb.50.1","mag":"2116358656","pmid":"https://pubmed.ncbi.nlm.nih.gov/11824567"},"language":"en","primary_location":{"id":"doi:10.1248/cpb.50.1","doi":"https://doi.org/10.1248/cpb.50.1","is_oa":true,"landing_page_url":"https://doi.org/10.1248/cpb.50.1","pdf_url":"https://www.jstage.jst.go.jp/article/cpb/50/1/50_1_1/_pdf","source":{"id":"https://openalex.org/S3861430","display_name":"Chemical and Pharmaceutical Bulletin","issn_l":"0009-2363","issn":["0009-2363","1347-5223"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chemical and Pharmaceutical Bulletin","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2116358656"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.jstage.jst.go.jp/article/cpb/50/1/50_1_1/_pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032412691","display_name":"Barry M. Trost","orcid":"https://orcid.org/0000-0001-7369-9121","observed_orcids":["https://orcid.org/0000-0001-7369-9121"]},"institutions":[{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Barry M. Trost","raw_affiliation_strings":["Department of Chemistry, Stanford University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Stanford University","institution_ids":["https://openalex.org/I97018004"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5032412691"],"corresponding_institution_ids":["https://openalex.org/I97018004"],"apc_list":null,"apc_paid":null,"fwci":1.4998,"has_fulltext":true,"cited_by_count":370,"citation_normalized_percentile":{"value":0.78172589,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":97,"max":100},"biblio":{"volume":"50","issue":"1","first_page":"1","last_page":"14"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10013","display_name":"Asymmetric Synthesis and Catalysis","score":0.9848999977111816,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10013","display_name":"Asymmetric Synthesis and Catalysis","score":0.9848999977111816,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10548","display_name":"Catalytic Cross-Coupling Reactions","score":0.009700000286102295,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11281","display_name":"Asymmetric Hydrogenation and Catalysis","score":0.0034000000450760126,"subfield":{"id":"https://openalex.org/subfields/1604","display_name":"Inorganic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/palladium-catalysis","display_name":"palladium catalysis","score":0.8360000252723694},{"id":"https://openalex.org/keywords/asymmetric-allylic-alkylation","display_name":"asymmetric allylic alkylation","score":0.9990000128746033},{"id":"https://openalex.org/keywords/asymmetric-induction","display_name":"asymmetric induction","score":0.7900000214576721},{"id":"https://openalex.org/keywords/chiral-ligands","display_name":"chiral ligands","score":0.8889999985694885},{"id":"https://openalex.org/keywords/1-naphthoic-acid","display_name":"1-naphthoic acid","score":0.9520000219345093},{"id":"https://openalex.org/keywords/chiral-diamines","display_name":"chiral diamines","score":0.9369999766349792},{"id":"https://openalex.org/keywords/enantioselectivity","display_name":"enantioselectivity","score":0.8109999895095825},{"id":"https://openalex.org/keywords/total-synthesis","display_name":"total synthesis","score":0.5249999761581421},{"id":"https://openalex.org/keywords/natural-products","display_name":"natural products","score":0.6539999842643738},{"id":"https://openalex.org/keywords/adenosine","display_name":"adenosine","score":0.6240000128746033},{"id":"https://openalex.org/keywords/aflatoxin-b","display_name":"aflatoxin B","score":0.9300000071525574},{"id":"https://openalex.org/keywords/aristeromycin","display_name":"aristeromycin","score":0.9779999852180481},{"id":"https://openalex.org/keywords/calanolide-a","display_name":"calanolide A","score":0.753000020980835},{"id":"https://openalex.org/keywords/cyclophellitol","display_name":"cyclophellitol","score":0.8730000257492065},{"id":"https://openalex.org/keywords/ethambutol","display_name":"ethambutol","score":0.8849999904632568},{"id":"https://openalex.org/keywords/galantamine","display_name":"galantamine","score":0.9649999737739563},{"id":"https://openalex.org/keywords/vigabatrin","display_name":"vigabatrin","score":0.9800000190734863},{"id":"https://openalex.org/keywords/valienamine","display_name":"valienamine","score":0.9980000257492065}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9026315212249756},{"id":"https://openalex.org/C27083343","wikidata":"https://www.wikidata.org/wiki/Q900629","display_name":"Tsuji\u2013Trost reaction","level":4,"score":0.8617820739746094},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.6700206995010376},{"id":"https://openalex.org/C120095180","wikidata":"https://www.wikidata.org/wiki/Q2695010","display_name":"Allylic rearrangement","level":3,"score":0.6034013628959656},{"id":"https://openalex.org/C486523","wikidata":"https://www.wikidata.org/wiki/Q494483","display_name":"Enantiomer","level":2,"score":0.5576457977294922},{"id":"https://openalex.org/C146686406","wikidata":"https://www.wikidata.org/wiki/Q898628","display_name":"Enantioselective synthesis","level":3,"score":0.4735102951526642},{"id":"https://openalex.org/C190603991","wikidata":"https://www.wikidata.org/wiki/Q752656","display_name":"Asymmetric induction","level":4,"score":0.4509064257144928},{"id":"https://openalex.org/C75079739","wikidata":"https://www.wikidata.org/wiki/Q1571801","display_name":"Intramolecular force","level":2,"score":0.44960716366767883},{"id":"https://openalex.org/C124668440","wikidata":"https://www.wikidata.org/wiki/Q2305173","display_name":"Chirality (physics)","level":5,"score":0.4329376518726349},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.4166260361671448},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.1965998411178589},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.14168787002563477},{"id":"https://openalex.org/C62520636","wikidata":"https://www.wikidata.org/wiki/Q944","display_name":"Quantum mechanics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C7602139","wikidata":"https://www.wikidata.org/wiki/Q6718","display_name":"Quark","level":2,"score":0.0},{"id":"https://openalex.org/C52703039","wikidata":"https://www.wikidata.org/wiki/Q5101837","display_name":"Chiral symmetry breaking","level":3,"score":0.0},{"id":"https://openalex.org/C20621625","wikidata":"https://www.wikidata.org/wiki/Q6961432","display_name":"Nambu\u2013Jona-Lasinio model","level":4,"score":0.0}],"mesh":[{"descriptor_ui":"D000478","descriptor_name":"Alkylation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000498","descriptor_name":"Allyl Compounds","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D000498","descriptor_name":"Allyl Compounds","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D002384","descriptor_name":"Catalysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008024","descriptor_name":"Ligands","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008956","descriptor_name":"Models, Chemical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010165","descriptor_name":"Palladium","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D013237","descriptor_name":"Stereoisomerism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1248/cpb.50.1","doi":"https://doi.org/10.1248/cpb.50.1","is_oa":true,"landing_page_url":"https://doi.org/10.1248/cpb.50.1","pdf_url":"https://www.jstage.jst.go.jp/article/cpb/50/1/50_1_1/_pdf","source":{"id":"https://openalex.org/S3861430","display_name":"Chemical and Pharmaceutical Bulletin","issn_l":"0009-2363","issn":["0009-2363","1347-5223"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chemical and Pharmaceutical Bulletin","raw_type":"journal-article"},{"id":"pmid:11824567","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11824567","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chemical & pharmaceutical bulletin","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1248/cpb.50.1","doi":"https://doi.org/10.1248/cpb.50.1","is_oa":true,"landing_page_url":"https://doi.org/10.1248/cpb.50.1","pdf_url":"https://www.jstage.jst.go.jp/article/cpb/50/1/50_1_1/_pdf","source":{"id":"https://openalex.org/S3861430","display_name":"Chemical and Pharmaceutical Bulletin","issn_l":"0009-2363","issn":["0009-2363","1347-5223"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chemical and Pharmaceutical Bulletin","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320306076","display_name":"National Science Foundation","ror":"https://ror.org/021nxhr62"},{"id":"https://openalex.org/F4320306095","display_name":"American Cancer Society","ror":"https://ror.org/02e463172"},{"id":"https://openalex.org/F4320308269","display_name":"Alexander von Humboldt-Stiftung","ror":"https://ror.org/012kf4317"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2116358656.pdf","grobid_xml":"https://content.openalex.org/works/W2116358656.grobid-xml"},"referenced_works_count":80,"referenced_works":["https://openalex.org/W639396170","https://openalex.org/W1506938930","https://openalex.org/W1963820689","https://openalex.org/W1963983906","https://openalex.org/W1964626545","https://openalex.org/W1966933317","https://openalex.org/W1970357928","https://openalex.org/W1970479980","https://openalex.org/W1970771571","https://openalex.org/W1980603355","https://openalex.org/W1984296115","https://openalex.org/W1986001811","https://openalex.org/W1987624533","https://openalex.org/W2000311839","https://openalex.org/W2005676377","https://openalex.org/W2009372668","https://openalex.org/W2009434036","https://openalex.org/W2009835202","https://openalex.org/W2010759416","https://openalex.org/W2011996195","https://openalex.org/W2016613405","https://openalex.org/W2018512976","https://openalex.org/W2021217244","https://openalex.org/W2023102133","https://openalex.org/W2025412311","https://openalex.org/W2036778205","https://openalex.org/W2040556955","https://openalex.org/W2040972811","https://openalex.org/W2045478710","https://openalex.org/W2052074092","https://openalex.org/W2063071835","https://openalex.org/W2066356560","https://openalex.org/W2078882260","https://openalex.org/W2081807638","https://openalex.org/W2082099636","https://openalex.org/W2083135594","https://openalex.org/W2085189843","https://openalex.org/W2086971716","https://openalex.org/W2087776280","https://openalex.org/W2088928943","https://openalex.org/W2089339796","https://openalex.org/W2092814460","https://openalex.org/W2098438354","https://openalex.org/W2100121134","https://openalex.org/W2100206464","https://openalex.org/W2101826827","https://openalex.org/W2111114110","https://openalex.org/W2112058216","https://openalex.org/W2113469148","https://openalex.org/W2128689958","https://openalex.org/W2130642047","https://openalex.org/W2140067386","https://openalex.org/W2156872638","https://openalex.org/W2312290708","https://openalex.org/W2337242153","https://openalex.org/W2949107901","https://openalex.org/W2949167448","https://openalex.org/W2949342085","https://openalex.org/W2949465831","https://openalex.org/W2949675253","https://openalex.org/W2949675274","https://openalex.org/W2949779097","https://openalex.org/W2950336330","https://openalex.org/W2950423229","https://openalex.org/W2950535230","https://openalex.org/W2951527893","https://openalex.org/W2951580677","https://openalex.org/W2951770305","https://openalex.org/W2952172732","https://openalex.org/W2952280905","https://openalex.org/W2952386105","https://openalex.org/W2952395312","https://openalex.org/W2952474586","https://openalex.org/W2952620206","https://openalex.org/W2952717383","https://openalex.org/W2952971450","https://openalex.org/W2953009601","https://openalex.org/W2953119657","https://openalex.org/W2953313782","https://openalex.org/W2953367984"],"related_works":["https://openalex.org/W2176634115","https://openalex.org/W2952430222","https://openalex.org/W2951806339","https://openalex.org/W6998405984","https://openalex.org/W2952305385","https://openalex.org/W2584148467","https://openalex.org/W2034826608","https://openalex.org/W2949760282","https://openalex.org/W2949888965","https://openalex.org/W4252680261"],"abstract_inverted_index":{"Palladium":[0],"catalyzed":[1],"asymmetric":[2,30,37],"allylic":[3],"alkylations":[4],"represent":[5],"a":[6,65],"challenging":[7],"problem":[8],"because":[9],"the":[10,13,16,21,29],"mechanism":[11],"of":[12,46,52,67,102],"reaction":[14],"places":[15],"chiral":[17,76],"environment":[18],"distal":[19],"to":[20],"bond":[22],"breaking":[23],"or":[24,72],"making":[25],"events":[26],"responsible":[27],"for":[28,44],"induction.":[31],"Furthermore,":[32],"unlike":[33],"virtually":[34],"every":[35],"other":[36],"process,":[38],"many":[39,49],"strategies":[40,97],"can":[41,54],"be":[42,55],"employed":[43],"introduction":[45],"asymmetry":[47],"and":[48,75,106,114,125,129],"different":[50,60,88],"types":[51],"bonds":[53],"formed.":[56],"While":[57],"over":[58],"100":[59],"ligands":[61,68],"have":[62,79,93],"been":[63,80],"designed,":[64],"family":[66],"derived":[69],"from":[70],"2-diphenylphosphinobenzoic":[71],"1-naphthoic":[73],"acid":[74],"scalemic":[77],"diamines":[78],"successful":[81],"in":[82],"inducing":[83],"excellent":[84],"enantioselectivity":[85],"by":[86],"five":[87],"enantiodiscriminating":[89],"events.":[90],"These":[91],"methods":[92],"already":[94],"provided":[95],"practical":[96],"towards":[98],"numerous":[99],"biological":[100],"targets--some":[101],"which":[103],"are":[104],"adenosine":[105],"its":[107],"enantiomer,":[108],"aflatoxin":[109],"B,":[110,115],"aristeromycin,":[111],"calanolide":[112],"A":[113],"carbovir,":[116],"cyclophellitol,":[117],"ethambutol,":[118],"galanthamine,":[119],"mannostatin,":[120],"neplanocin,":[121],"phyllanthocin,":[122],"sphingofungins":[123],"E":[124],"F,":[126],"tetraponaines,":[127],"vigabatrin,":[128],"valienamine.":[130]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2116358656","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":10},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":10},{"year":2021,"cited_by_count":15},{"year":2020,"cited_by_count":16},{"year":2019,"cited_by_count":13},{"year":2018,"cited_by_count":11},{"year":2017,"cited_by_count":15},{"year":2016,"cited_by_count":11},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":11},{"year":2013,"cited_by_count":16},{"year":2012,"cited_by_count":20}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
